Results 181 to 190 of about 19,801 (209)

CD138 Antigen

2018
openaire   +1 more source

Evaluation of BCL-6, CD10, CD138 and MUM-1 Expression in Diffuse Large B-Cell Lymphoma patients: CD138 is a Marker of Poor Prognosis

Asian Pacific Journal of Cancer Prevention, 2012
Yazan Haddad, Khaldon Bodoor
exaly  

The potential diagnostic power of CD138+ microparticles from the plasma analysis for multiple myeloma clinical monitoring

Hematological Oncology, 2019
Mengyue Tian
exaly  

USES OF IMMUNOCONJUGATES TARGETING CD138

2013
FRANK OSTERROTH, CHRISTOPH UHEREK, CHRISTOPH BRUECHER, BENJAMIN DAELKEN, ANDRE ENGLING, THOMAS HAEDER, ANDREA WARTENBERG-DEMAND, GABRIELE NIEMANN, CHANTAL ZUBER, NIKLAS CZELOTH, SILKE AIGNER, STEFFEN ZENG, GREGOR SCHULZ   +12 more
openaire   +7 more sources

Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas

Diagnostic Cytopathology, 2005
Alain Borczuk, Charles Powell
exaly  

XBP1, CD138, AND CS1 PEPTIDES

2011
MUNSHI NIKHIL C, ANDERSON KENNETH C, BAE JOOEUN   +2 more
openaire   +5 more sources

Endometrial CD138 count appears to be a negative prognostic indicator for patients who have experienced previous embryo transfer failure

Fertility and Sterility, 2019
Yuan Li, Jingnan Liao, Jing Guo
exaly  

TARGETING CD138 IN CANCER

2014
DOTTI GIANPIETRO, RAMOS CARLOS A, SAVOLDO BARBARA   +2 more
openaire   +7 more sources

HUMANIZED ANTIBODY MOLECULES TO CD138 AND USES THEREOF

2020
CHAGANTY BHARAT, RAMAKRISHNAN BOOPATHY, ADARI-HALL HEDY, VISWANATHAN KARTHIK, MYETTE JAMES, SHRIVER ZACHARY, WOLLACOTT ANDREW   +6 more
openaire   +4 more sources

Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions

Modern Pathology, 2001
Ralph Sanderson, Sanderson Ralph D, C S Wilson   +2 more
exaly